| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/21/2002 | WO2002014521A2 Plants having modified growth properties |
| 02/21/2002 | WO2002014520A2 Process for inducing direct somatic embryogenesis and secondary embryogenesis in monocotyledonous plant cells, and rapidly regenerating fertile plants |
| 02/21/2002 | WO2002014519A1 A method to increase cerebral blood flow in amyloid angiopathy |
| 02/21/2002 | WO2002014518A1 Method of modifying microorganism-origin transglutaminase |
| 02/21/2002 | WO2002014517A1 BROAD-SPECTRUM δ-ENDOTOXINS |
| 02/21/2002 | WO2002014516A1 Novel diagnostic agents of chronic or persistent chlamydial diseases and uses thereof |
| 02/21/2002 | WO2002014515A1 Nucleic acids and proteins showing increased expression dose under salt stress |
| 02/21/2002 | WO2002014514A1 A fibrinogen clotting inhibitor derived from snake venom and process for preparing the same |
| 02/21/2002 | WO2002014513A1 Use of polypeptide |
| 02/21/2002 | WO2002014512A1 Novel proteins and dnas thereof |
| 02/21/2002 | WO2002014511A2 Regulation of human p2y1-like g protein-coupled receptor |
| 02/21/2002 | WO2002014510A1 A novel polypeptide- human cbp20 protein 47.74 and the polynucleotide encoding said polypeptide |
| 02/21/2002 | WO2002014508A2 Arrayed collection of genomic clones |
| 02/21/2002 | WO2002014507A1 Method of elevating the ratio of transformed individuals by using selfish gene |
| 02/21/2002 | WO2002014505A1 Collagen-binding hybrid polypeptide |
| 02/21/2002 | WO2002014503A2 Compositions and methods for the therapy and diagnosis of her-2/neu-associated malignancies |
| 02/21/2002 | WO2002014502A2 Sclerotinia-inducible genes and promoters and their uses |
| 02/21/2002 | WO2002014500A2 Human genes and gene expression products |
| 02/21/2002 | WO2002014499A2 Claudin polypeptides |
| 02/21/2002 | WO2002014498A2 Human voltage-gated sodium channel proteins (scn1a) and polynucleotides encoding the same |
| 02/21/2002 | WO2002014497A2 Genes encoding mutant p-coumarate 3-hydroxylase (c3h) and methods of use |
| 02/21/2002 | WO2002014496A2 G protein-coupled receptors |
| 02/21/2002 | WO2002014495A2 Enhanced homologous recombination mediated by lambda recombination proteins |
| 02/21/2002 | WO2002014494A2 Use of a transgene encoding a vertebrate phytase to increase capacity to utilize phytic acid in livestock feed |
| 02/21/2002 | WO2002014492A2 Fatty liver disease resistant bovines |
| 02/21/2002 | WO2002014490A2 Bacillus transformation, transformants and mutant libraries |
| 02/21/2002 | WO2002014489A2 Leucine-rich repeat-containing g-protein coupled receptor-8 molecules and uses thereof |
| 02/21/2002 | WO2002014488A1 Novel protein derived from agkistrodon saxatilis emelianov and process for preparing the same |
| 02/21/2002 | WO2002014487A2 Adeno-associated virus-mediated delivery of angiogenic factors |
| 02/21/2002 | WO2002014486A2 Inhibition of generative propagation in genetically modified grasses |
| 02/21/2002 | WO2002014485A2 Kallikrein gene |
| 02/21/2002 | WO2002014483A2 Human adenosine deaminase |
| 02/21/2002 | WO2002014482A2 Polyketides and their synthesis |
| 02/21/2002 | WO2002014478A2 IMMUNOGENIC HBc CHIMER PARTICLES HAVING ENHANCED STABILITY |
| 02/21/2002 | WO2002014474A2 Method of treating alzheimer's disease with cell therapy |
| 02/21/2002 | WO2002014473A2 Animals expressing exogenous igf-i in their milk |
| 02/21/2002 | WO2002014472A2 Improved methods of gene silencing using inverted repeat sequences |
| 02/21/2002 | WO2002014471A2 A method of producing biologically active human acidic fibroblast growth factor and its use in promoting angiogenesis |
| 02/21/2002 | WO2002014470A2 Expression of herstatin, an alternative her-2/neu product, in cells that express either p185her-2 or the egf receptor inhibits receptor activity and cell growth |
| 02/21/2002 | WO2002014468A2 Phage-dependent superproduction of biologically active protein and peptides |
| 02/21/2002 | WO2002014467A2 Cng2b: a putative human cyclic nucleotide-gated ion channel |
| 02/21/2002 | WO2002014463A2 Method for genetic transformation of woody trees |
| 02/21/2002 | WO2002014369A2 Human kininogen d5 domain polypeptides and their use |
| 02/21/2002 | WO2002014367A1 Chimeric human-type vascular endothelial cell growth factor |
| 02/21/2002 | WO2002014366A2 Genes involved in immune related responses observed with asthma |
| 02/21/2002 | WO2002014365A1 A new polypeptide-ras gtp activator protein 12 and the polynucleotide encoding it |
| 02/21/2002 | WO2002014364A2 Rattlesnake venom gland proteins |
| 02/21/2002 | WO2002014363A2 Influencing the distribution of metals in transgenic plants |
| 02/21/2002 | WO2002014362A2 A hepatitis c virus non-structural ns3/4a fusion gene |
| 02/21/2002 | WO2002014355A2 Novel mitogen activated kinase |
| 02/21/2002 | WO2002014352A2 Therapeutic compounds for ovarian cancer |
| 02/21/2002 | WO2002014348A2 Glycoproteins and methods of use thereof |
| 02/21/2002 | WO2002013862A2 Method and composition for altering a b cell mediated pathology |
| 02/21/2002 | WO2002013861A2 Method and composition for altering a t cell mediated pathology |
| 02/21/2002 | WO2002013855A2 Vaccines containing ribavirin and methods of use thereof |
| 02/21/2002 | WO2002013848A1 Highly homogeneous molecular markers for electrophoresis |
| 02/21/2002 | WO2002013845A2 Inflammation related g-protein coupled receptor |
| 02/21/2002 | WO2002013837A1 A novel animal model of alzheimer's disease using genetically altered stem cells |
| 02/21/2002 | WO2002013799A2 Oligonucleotides and other modulators of the nk-1 receptor pathway and therapeutic uses thereof |
| 02/21/2002 | WO2002013765A2 Malaria immunogen and vaccine |
| 02/21/2002 | WO2002013763A2 Treatment of hiv-1 infection and inflammatory disease using cyclophilin receptor antagonists |
| 02/21/2002 | WO2002013758A2 System for regulating in vivo the expression of a transgene by conditional inhibition |
| 02/21/2002 | WO2002013610A1 Nucleic acid expression from linear nucleic acids |
| 02/21/2002 | WO2002013609A1 METHODS FOR BLOCKING RESISTANCE TO Bt TOXINS IN INSECTS AND NEMATODES |
| 02/21/2002 | WO2002013606A2 Improved insecticidal bacteria, and methods for making and using them |
| 02/21/2002 | WO2002013602A1 Transgenic non-human mammal and method of constructing the same, animal disease model and method of clarifying gene function |
| 02/21/2002 | WO2001083698A3 Compositions and methods for inducing activation of dendritic cells |
| 02/21/2002 | WO2001081608A3 Viral vectors for use in monitoring hiv drug resistance |
| 02/21/2002 | WO2001080639A3 Hr-elicitors to inhibit postharvest disease or desiccation of fruits or vegetables |
| 02/21/2002 | WO2001079443A3 Albumin fusion proteins |
| 02/21/2002 | WO2001077336A3 Acyl-coa dehydrogenase mutant and uses thereof |
| 02/21/2002 | WO2001077329A8 Human twik molecules and uses thereof |
| 02/21/2002 | WO2001077149A3 Regulation of human cyslt2-like gpcr protein |
| 02/21/2002 | WO2001076529A3 Fertility associated antigen and methods of use thereof |
| 02/21/2002 | WO2001072977A3 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 02/21/2002 | WO2001070807A3 G-protein associated molecules |
| 02/21/2002 | WO2001068849A8 Human ion channels |
| 02/21/2002 | WO2001068846A3 Transcription activator of the cited family |
| 02/21/2002 | WO2001068802A3 Genes of il-12p40 subunit mutated for improving the activity of il-12 and use thereof for dna vaccine adjuvant |
| 02/21/2002 | WO2001066768A8 Dna molecule coding for a polygalacturonase of strawberry and the uses thereof |
| 02/21/2002 | WO2001066747A8 Proteins named fctrx and nucleic acids encoding same |
| 02/21/2002 | WO2001066704A3 Methods for making plants tolerant to glyphosate and compositions thereof |
| 02/21/2002 | WO2001066597A3 Inflammation-related gene |
| 02/21/2002 | WO2001064910A3 Atpase-like molecule and uses thereof |
| 02/21/2002 | WO2001064860A3 Recombinant influenza a viruses |
| 02/21/2002 | WO2001064240A3 Methods for promoting production of myelin by schwann cells |
| 02/21/2002 | WO2001059138A3 Plant internal ribosome entry segment |
| 02/21/2002 | WO2001059116A3 19459 protein, a human g-protein coupled seven transmembrane receptor |
| 02/21/2002 | WO2001059110A3 34p3d7: a tissue specific protein highly expressed in prostate cancer |
| 02/21/2002 | WO2001058953A3 Identification of a domain in the tumor necrosis factor receptor family that mediates pre-ligand receptor assembly and function |
| 02/21/2002 | WO2001058484A3 Novel uses of mammalian ccr8 receptors and related reagents |
| 02/21/2002 | WO2001057264A3 Electron-deficient nitrogen heterocycle-substituted fluorescein dyes |
| 02/21/2002 | WO2001057213A3 Human bcl-x-like proteins and polynucleotides encoding the same |
| 02/21/2002 | WO2001057198A3 Methods of generating protein expression arrays and the use thereof in rapid screening |
| 02/21/2002 | WO2001057069A3 Targeting peptides |
| 02/21/2002 | WO2001055391A3 84p2a9: a prostate and testis specific protein highly expressed in prostate cancer |
| 02/21/2002 | WO2001055319A3 Endocrine related nucleic acids, proteins and antibodies |
| 02/21/2002 | WO2001053532A3 Barcoded synthetic lethal screening to identify drug targets |
| 02/21/2002 | WO2001053478A3 Methods for regulating transcription in plants by introduction of engireed zinc finger polypeptides |
| 02/21/2002 | WO2001053475A3 Isolation and characterization of a n. crassa silencing gene and uses thereof |